Lupus Erythematosus, Systemic: all 1,222 studies

Page 6 of 13. Open to participants first (399), then studies with results posted, then the rest; newest registration first within each.

• A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus.CompletedNCT02185040Phase 2Results posted
• Systemic Lupus Erythematous and Heart Conduction DisordersCompletedNCT02162992Results posted
• A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an AutoinjectorCompletedNCT02124798Phase 2Results posted
• Belimumab Treatment Holiday and Treatment Re-start Study in Lupus PatientsCompletedNCT02119156Phase 3Results posted
• Low-dose IL-2( Interleukin-2) Treatment in SLECompletedNCT02084238Not applicableResults posted
• Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II)TerminatedNCT02070978Phase 2Results posted
• Nelfinavir in Systemic Lupus ErythematosusTerminatedNCT02066311Phase 2Results posted
• A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With LupusTerminatedNCT02041091Phase 3Results posted
• Efficacy and Safety of Atacicept in Systemic Lupus ErythematosusCompletedNCT01972568Phase 2Results posted
• Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE)TerminatedNCT01946880Phase 2Results posted
• Vitamin D to Improve Endothelial Function in SLECompletedNCT01911169Phase 2Results posted
• IVIg Efficacy Study to Treat Cutaneous Lupus ErythematosusCompletedNCT01841619Early Phase 1Results posted
• Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE.CompletedNCT01838694Phase 1/2Results posted
• Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE)TerminatedNCT01781611Not applicableResults posted
• Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active DiseaseCompletedNCT01753401Phase 4Results posted
• An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in AdultsCompletedNCT01753193Phase 2Results posted
• Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus PatientsCompletedNCT01741012Phase 1Results posted
• Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) RegistryCompletedNCT01729455Results posted
• Vitamin D3 Treatment in Pediatric Systemic Lupus ErythematosusTerminatedNCT01709474Phase 2Results posted
• Belimumab Assessment of Safety in SLECompletedNCT01705977Phase 4Results posted
• A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus TreatmentCompletedNCT01689350Not applicableResults posted
• Pediatric Lupus Trial of Belimumab Plus Background Standard TherapyCompletedNCT01649765Phase 2Results posted
• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE)CompletedNCT01632241Phase 4Results posted
• Effectiveness of a Knowledge-based Intervention for Patients With Cutaneous Lupus ErythematosusCompletedNCT01629784Not applicableResults posted
• BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115CompletedNCT01597622Phase 3Results posted
• A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01597492Phase 4Results posted
• Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) LesionsCompletedNCT01597050Phase 2Results posted
• Use of Cross-linked Donor Corneas as Carriers for the Boston KeratoprosthesisCompletedNCT01582880Phase 1/2Results posted
• Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus.CompletedNCT01559090Phase 2Results posted
• On Open-Label Study in Participants With Systemic Lupus ErythematosusTerminatedNCT01488708Phase 3Results posted
• A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT01484496Phase 3Results posted
• A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus ErythematosusCompletedNCT01438489Phase 2Results posted
• Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusCompletedNCT01408576Phase 3Results posted
• Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus ErythematosusCompletedNCT01405196Phase 2Results posted
• GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast AsiaCompletedNCT01345253Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus ErythematosusCompletedNCT01283139Phase 2Results posted
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus ErythematosusCompletedNCT01262365Phase 3Results posted
• Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE)CompletedNCT01261793Phase 3Results posted
• GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic DiseasesTerminatedNCT01257802Phase 3Results posted
• A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus ErythematosusTerminatedNCT01240694Phase 3Results posted
• A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01205438Phase 3Results posted
• A Study of LY2127399 in Participants With Systemic Lupus ErythematosusCompletedNCT01196091Phase 3Results posted
• A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE)CompletedNCT01135459Phase 2Results posted
• A Safety and Tolerability Study of MEDI-570 in Systemic Lupus ErythematosusTerminatedNCT01127321Phase 1Results posted
• A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus NephritisCompletedNCT01085097Phase 2Results posted
• A Study of Laquinimod in Participants With Systemic Lupus Erythematosus (SLE) Active Lupus ArthritisCompletedNCT01085084Phase 2Results posted
• A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus.CompletedNCT01031836Phase 2Results posted
• Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE)CompletedNCT00987831Phase 1/2Results posted
• A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or MyositisCompletedNCT00979654Phase 2Results posted
• Efficacy of Fish Oil in Lupus PatientsCompletedNCT00828178Phase 4Results posted
• Immunogenicity and Safety of HPV Vaccine Gardasil in Young WomenCompletedNCT00786409Not applicableResults posted
• Prospective Study of Rapamycin for the Treatment of SLECompletedNCT00779194Phase 2Results posted
• Abatacept and Cyclophosphamide Combination Therapy for Lupus NephritisCompletedNCT00774852Phase 2Results posted
• Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED)TerminatedNCT00739050Phase 4Results posted
• Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)TerminatedNCT00732940Phase 2Results posted
• A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United StatesCompletedNCT00724867Phase 3Results posted
• A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057CompletedNCT00712933Phase 3Results posted
• Vitamin D3 in Systemic Lupus ErythematosusCompletedNCT00710021Phase 2Results posted
• Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc)TerminatedNCT00684255Phase 1Results posted
• Evaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)CompletedNCT00633945Not applicableResults posted
• A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG)TerminatedNCT00626197Phase 3Results posted
• Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE)CompletedNCT00624338Phase 2/3Results posted
• Biomarker-Linked Outcomes of Cellcept in Lupus ArthritisCompletedNCT00594932Phase 1/2Results posted
• A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02CompletedNCT00583362Phase 2Results posted
• A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN)TerminatedNCT00539838Phase 3Results posted
• Efficacy and Safety Study of Abatacept to Treat Lupus NephritisTerminatedNCT00430677Phase 2/3Results posted
• A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00424476Phase 3Results posted
• A Study of Belimumab in Subjects With Systemic Lupus ErythematosusCompletedNCT00410384Phase 3Results posted
• Sirolimus for Autoimmune Disease of Blood CellsCompletedNCT00392951Phase 1/2Results posted
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusTerminatedNCT00381810Phase 3Results posted
• Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus ErythematosusCompletedNCT00278538Phase 2Results posted
• A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus ErythematosusCompletedNCT00137969Phase 2/3Results posted
• Triptorelin for Ovary Protection in Childhood Onset LupusCompletedNCT00124514Phase 2Results posted
• Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With PrednisoneCompletedNCT00119678Phase 2Results posted
• Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus ErythematosusCompletedNCT00076752Phase 2Results posted
• Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)CompletedNCT00071487Phase 2Results posted
• Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)CompletedNCT00065806Phase 3Results posted
• Feasibility and Performance of a Structured Video Telemedicine Program in Patients With Systemic Lupus ErythematousCompletedNCT07840573Not applicable
• Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus NephritisActive, not recruitingNCT07678203Phase 1/2
• A Clinical Study to Evaluate LVIVO-TaVec400 for the Treatment of Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07583030Early Phase 1
• Lupus Walking Intervention to Address Fatigue/Quality of LifeCompletedNCT07481214Not applicable
• UCAR T-cell Therapy Targeting CD19/ BCMA(QT-019C) in Patients With Relapse/ Refractory Autoimmune DiseasesWithdrawnNCT07410377Early Phase 1
• Assessing the Impact of Herbal Supplement on Fatigue and Disease Activity in SLE: Results From an 8-Week Randomized TrialCompletedNCT07398885Not applicable
• Efficacy and Safety of IL-1 Inhibitors in Mild to Moderate Systemic Lupus ErythematosusActive, not recruitingNCT07381465Phase 4
• Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune DiseasesWithdrawnNCT07361094Phase 1
• the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory Autoimmune DiseasesActive, not recruitingNCT07339540Early Phase 1
• EG-501 for Cognitive Impairment in Neuropsychiatric SLE (NPSLE): Efficacy and Safety StudyCompletedNCT07281105Phase 2
• The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy StudyCompletedNCT07267091
• A Study to Evaluate the Safety,Tolerability,Pharmacokinetics and Pharmacodynamics of Cenerimod in Adult Chinese Participants With Moderate-to-severe Systemic Lupus Erythematosus (SLE)Active, not recruitingNCT07266090Phase 2
• Vagus Nerve Stimulation for Fatigue in Systemic LupusCompletedNCT07256067Not applicable
• HEAL-SLE: Holistic Energy for Alleviating Lupus SymptomsActive, not recruitingNCT07203157Not applicable
• A Multi-component, Person-centered, and Yoga-based Coaching Program for Lupus Chronic PainActive, not recruitingNCT07196072Not applicable
• Respiratory Function, Physical Activity and Fatigue in SLECompletedNCT07193745
• UCAR T-cell Therapy Targeting CD19/ BCMA in Patients With Relapse/ Refractory Autoimmune DiseasesActive, not recruitingNCT07155369Not applicable
• Prognostic Factors for Fatigue in Patients With Systemic Lupus ErythematosusCompletedNCT07123220
• Study of CM355 in Patients With Systemic Lupus ErythematosusActive, not recruitingNCT07104344Not applicable
• Lupus Arthritis: Muscoloskeletal Ultrasound as Clinical Outcome of Peripheral Blood and Synovial Deep PhenotypingActive, not recruitingNCT07102238Not applicable
• The Effect of Co-enzyme Q10 on the Clinical Outcome of Pediatric Patients With Systemic Lupus ErythematosusCompletedNCT07096557Phase 2
• Efficacy of Vitamin C Supplementation on Malondialdehid Levels and Disease Activity in SLE PatientsCompletedNCT07083622Not applicable
• NK510 Cell Therapy for Refractory Systemic Lupus ErythematosusTerminatedNCT07083349Early Phase 1

← Lupus Erythematosus, Systemic overview